With a grant from the ACR’s Rheumatology Research Foundation, Nancy J. Olsen, MD, hopes to discover how methotrexate interacts with immune system cells and ultimately helps to control the system’s attack on joints
ACR Advances Legislation to Increase Patients’ Access to Biologic Drugs to Treat Rheumatoid Arthritis and Other Conditions
The Patients’ Access to Treatments Act of 2013 would prevent insurance companies from tacking on an additional cost-sharing fee for the specialty medications
Five Quick Ways To Make a Difference in Rheumatology Through Advocacy
The ACR’s online advocacy page has position statements and work plans on issues affecting rheumatology, and offers ways to get involved
Coding Corner Answer: March Coding Challenge
Coding for a patient with two established problems, and elements needed to code an extended history of present illness, and a comprehensive history level for a new patient
Coding Corner Question: March
Test your coding knowledge of evaluation and management components
Practice Page: Education and Training in Medical Coding, Billing, and Audit Regulations Is Essential for Healthcare Providers
The ACR provides a one-day educational coding course to help rheumatology services stay up to date with rules and guidelines
ACR/ARHP Annual Meeting 2012: Federal Act Aims to Make New Biologic Drugs Available to Rheumatology Patients at a Lower Cost
The Biologics Price Competition and Innovation Act of 2009 would spur the development of products intended to be biosimilar to approved therapies
ACR/ARHP Annual Meeting 2012: Fatigue for People with Rheumatoid Arthritis Rooted in Physiological and Psychological Factors
Researchers find that genes, gender, and cognition all contribute to fatigue in rheumatoid arthritis (RA)
ACR/ARHP Annual Meeting 2012: Physicians Search for Ways to Improve Clinical Outcomes for Total Knee Replacements (TKR)
Widely variable results for people post-TKR procedures have prompted doctors to develop a standardized approach to rehabilitation care
ACR/ARHP Annual Meeting 2012: Risk of Immunosuppression from Rheumatic Disease Therapies Poses Challenge for Rheumatologists
Therapies can raise patients’ risk of contracting tuberculosis or other infectious diseases, complicating treatment
- « Previous Page
- 1
- …
- 671
- 672
- 673
- 674
- 675
- …
- 826
- Next Page »